COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran
Abdorahimi M, Pakdel F, Salehi M, Alcazar-Fuoli L, Hashemi SJ, Daie Ghazvini R, Ahmadkhani F, Ahmadikia K, Abdollahi A, Debran JCS, Tabari A, Farrokh F, Mousavand A, Afarinesh Khaki P, Salami Khaneshan A, Ibrahim AS, Khodavaisy S
.Mycopathologia. 2023 Sep 6. doi: 10.1007/s11046-023-00785-3. Epub ahead of print

Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern
Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A, Kord M, Dehghan Manshadi SA, Seifi A, Ghiasvand F, Khajavirad N, Ebrahimi S, Koohfar A, Boekhout T, Khodavaisy S
.Mycoses. 2020 Aug. doi: 10.1111/myc.13137. Epub 2020 Jul 23

Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran
Kord M, Salehi M, Hashemi SJ, Abdollahi A, Alijani N, Maleki A, Mahmoudi S, Ahmadikia K, Parsameher N, Moradi M, Abdorahimi M, Rezaie S, Hashemi Fesharaki SS, Abbasi K, Alcazar-Fuoli L, Khodavaisy S
.Curr Med Mycol. 2022 Sep. doi: 10.18502/cmm

Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran
Pakdel F, Ahmadikia K, Salehi M, Tabari A, Jafari R, Mehrparvar G, Rezaie Y, Rajaeih S, Alijani N, Barac A, Abdollahi A, Khodavaisy S
.Mycoses. 2021 Oct. doi: 10.1111/myc.13334. Epub 2021 Jul 1

Meningoencephalitis caused by Fusarium proliferatum: an unusual case
Alavi Darazam I, Sharifi G, Jamali E, Khodavaisy S, Javandoust Gharehbagh F, Hakamifard A
.Infection. 2022 Aug. doi: 10.1007/s15010-022-01761-7. Epub 2022 Feb 3

The Epidemiological, Clinical, Mycological, and Pathological Features of Rhino-cerebral Mucormycosis: A Systematic Review
Salehi M, Mahmoudi S, Rezahosseini O, Hashemi SJ, Ahmadikia K, Aala F, Khajavirad N, Alijani N, Izadi A, Getso MI, Abdollahi A, Salami A, Khatami SR, Adibimehr A, Hedayat Yaghoobi M, Sabahi M, Pazooki B, Yazdi F, Zebardast J, Saifi A, Hasan Nezhad M, Mardani M, Khodavaisy S
.Iran J Pathol. 2022 Spring. doi: 10.30699/IJP.2022.538690.2721. Epub 2022 Mar 8

In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates
Ahmadi A, Mahmoudi S, Rezaie S, Hashemi SJ, Dannaoui E, Badali H, Ghaffari M, Aala F, Izadi A, Maleki A, Meis JF, Khodavaisy S
.J Glob Antimicrob Resist. 2020 Jun. doi: 10.1016/j.jgar.2019.11.003. Epub 2019 Nov 9

Epidemiology of yeast species causing bloodstream infection in Tehran, Iran (2015-2017); superiority of 21-plex PCR over the Vitek 2 system for yeast identification
Kord M, Salehi M, Khodavaisy S, Hashemi SJ, Daie Ghazvini R, Rezaei S, Maleki A, Elmimoghaddam A, Alijani N, Abdollahi A, Doomanlou M, Ahmadikia K, Rashidi N, Pan W, Boekhout T, Arastehfar A
.J Med Microbiol. 2020 May. doi: 10.1099/jmm.0.001189. Epub 2020 Apr 28

In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris
Khodavaisy S, Gharehbolagh SA, Abdorahimi M, Rezaie S, Ahmadikia K, Badali H, Meis JF, Mahmoudi S
.Med Mycol. 2023 Jul. doi: 10.1093/mmy/myad069

Comparison of PCR-RFLP with 21-plex PCR and rDNA Sequencing for Identification of Clinical Yeast Isolates
Kord M, Elmimoghaddam A, Hashemi SJ, Reziae S, Daie Ghazvini R, Salehi M, Abdollahi A, Ahmadi A, Getso MI, Boekhout T, Khodavaisy S
.Mycopathologia. 2021 May. doi: 10.1007/s11046-020-00522-0. Epub 2021 Jan 4

Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia
Sasani E, Yadegari MH, Khodavaisy S, Rezaie S, Salehi M, Getso MI
.Mycopathologia. 2021 Dec. doi: 10.1007/s11046-021-00580-y. Epub 2021 Aug 19

Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran
Salehi M, Ahmadikia K, Badali H, Khodavaisy S
.Mycopathologia. 2020 Aug. doi: 10.1007/s11046-020-00472-7

Fungal keratitis in Iran: Risk factors, clinical features, and mycological profile
Soleimani M, Izadi A, Khodavaisy S, Dos Santos CO, Tehupeiory-Kooreman MC, Ghazvini RD, Hashemi SJ, Mousavi SAA, Aala F, Abdorahimi M, Aminizadeh M, Abedinifar Z, Mahmoudi S, Mohamadi A, Rezaie S, Verweij PE
.Front Cell Infect Microbiol. 2023 Jan. doi: 10.3389/fcimb.2023

The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis
Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali H, Mirhendi H, Salehi M, Tabari A, Mohammadi Ardehali M, Kord M, Roilides E, Rezaie S
.Mycoses. 2021 Aug. doi: 10.1111/myc.13256. Epub 2021 Mar 5

Pneumocystis pneumonia in COVID-19 patients: A comprehensive review
Sasani E, Bahrami F, Salehi M, Aala F, Bakhtiari R, Abdollahi A, Bashardoust B, Abdorahimi M, Khodavaisy S
.Heliyon. 2023 Feb. doi: 10.1016/j.heliyon.2023.e13618. Epub 2023 Feb 10